{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:02:33Z","timestamp":1780531353045,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jpba.2026.117553","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:04:57Z","timestamp":1778169897000},"page":"117553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Analytical quality by design-based development and validation of a robust impurity analysis method for albumin-bound paclitaxel nanoparticles"],"prefix":"10.1016","volume":"279","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6398-6555","authenticated-orcid":false,"given":"Hye","family":"Jeong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung-Chul","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4570-2159","authenticated-orcid":false,"given":"Young Ho","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gye Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2026.117553_bib1","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","article-title":"Paclitaxel (taxol)","volume":"332","author":"Rowinsky","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2026.117553_bib2","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1021\/ja00738a045","article-title":"Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia","volume":"93","author":"Wani","year":"1971","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jpba.2026.117553_bib3","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0960-894X(00)80348-0","article-title":"C-7 modifications of taxol","volume":"3","author":"Vyas","year":"1993","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jpba.2026.117553_bib4","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1021\/np000064n","article-title":"Recent advances in the chemistry of taxol","volume":"63","author":"Kingston","year":"2000","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.jpba.2026.117553_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40360-023-00653-2","article-title":"Study on the thermal stability of nab-paclitaxel during hyperthermic intraperitoneal chemotherapy","volume":"24","author":"Zhang","year":"2023","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.jpba.2026.117553_bib6","first-page":"115","article-title":"Stability of PTX in solution","volume":"113","author":"Xu","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2026.117553_bib7","first-page":"1377","article-title":"Separation and characterization of paclitaxel and its related compounds","volume":"12","author":"Sadeghi","year":"1994","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117553_bib8","article-title":"An effective method to produce 7-epitaxol from taxol in HCO3","volume":"30","author":"Zhou","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jpba.2026.117553_bib9","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","article-title":"Cremophor EL: the physicochemical and pharmacological properties of a pharmaceutical vehicle","volume":"37","author":"Gelderblom","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jpba.2026.117553_bib10","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1200\/JCO.2005.04.937","article-title":"Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-bound paclitaxel in women with metastatic breast cancer","volume":"23","author":"Gradishar","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jpba.2026.117553_bib11","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1158\/1078-0432.CCR-05-1634","article-title":"Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of nab-paclitaxel, compared with cremophor-based paclitaxel","volume":"12","author":"Desai","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jpba.2026.117553_bib12","first-page":"1038","article-title":"Phase I and pharmacokinetics study of ABI-007, a novel cremophor-free, albumin-bound particle form of paclitaxel","volume":"8","author":"Ibrahim","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jpba.2026.117553_bib13","first-page":"1","article-title":"Stabilizing mechanisms in commercial albumin preparations: octanoate and N-acetyl-L-tryptophanate protect human serum albumin against heat and oxidative stress","volume":"1702","author":"Anraku","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jpba.2026.117553_bib14","first-page":"101","article-title":"Simple and rapid HPLC-MS\/MS method for determination of paclitaxel in human plasma","volume":"881-882","author":"Zhao","year":"2012","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2026.117553_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3797\/scipharm.1507-03","article-title":"Development and validation of rapid RP-HPLC-DAD analysis method for simultaneous quantitation of paclitaxel and lapatinib in polymeric micelle formulation","volume":"84","author":"Saadat","year":"2016","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.jpba.2026.117553_bib16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0731-7085(03)00632-0","article-title":"A HPLC validated assay of paclitaxel\u2019s related impurities in pharmaceutical forms containing Cremophor EL","author":"Ciutaru","year":"2004","journal-title":"J. Pharm. Biomed. Anal. 34"},{"key":"10.1016\/j.jpba.2026.117553_bib17","first-page":"35","article-title":"Analytical quality by design, life cycle management, and method control","volume":"24","author":"Vetter","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jpba.2026.117553_bib18","unstructured":"International Council for Harmonisation, ICH Q8 (R2): Pharmaceutical Development, ICH, Geneva, 2009."},{"key":"10.1016\/j.jpba.2026.117553_bib19","unstructured":"United States Pharmacopeia, Paclitaxel Injection Monograph, USP 43-NF 38, United States Pharmacopeial Convention, Rockville, MD, 2020."},{"key":"10.1016\/j.jpba.2026.117553_bib20","unstructured":"International Council for Harmonisation, ICH Q14: Analytical Procedure Development, ICH, Geneva, 2023."},{"key":"10.1016\/j.jpba.2026.117553_bib21","unstructured":"United States Pharmacopeia, General Chapter <1220> Analytical Procedure Lifecycle, USP 43-NF 38, United States Pharmacopeial Convention, Rockville, MD, 2020."},{"key":"10.1016\/j.jpba.2026.117553_bib22","article-title":"Analytical quality by design in pharmaceutical development: optimization and validation of the chromatographic method for the determination of ambroxol hydrochloride","volume":"154","author":"Orlandini","year":"2020","journal-title":"Microchem. J."},{"key":"10.1016\/j.jpba.2026.117553_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.trac.2017.10.028","article-title":"'Quality by Design' approach for the analysis of impurities in pharmaceutical drug products and drug substances","volume":"101","author":"Dispas","year":"2018","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.jpba.2026.117553_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/868727","article-title":"Analytical quality by design: a tool for regulatory flexibility and robust analytics","volume":"2015","author":"Peraman","year":"2015","journal-title":"Int. J. Anal. Chem."},{"key":"10.1016\/j.jpba.2026.117553_bib25","doi-asserted-by":"crossref","DOI":"10.1590\/s2175-97902018000001006","article-title":"Design of Experiments (DoE) applied to pharmaceutical and analytical quality by design (QbD)","volume":"54","author":"Fukuda","year":"2018","journal-title":"Braz. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2026.117553_bib26","first-page":"187","article-title":"Quality by design: multidimensional exploration of the design space in high performance liquid chromatography method development","volume":"443","author":"Monks","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2026.117553_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.117206","article-title":"Strategic method development for praziquantel impurity analysis using analytical QbD framework","volume":"268","author":"Mastoras","year":"2026","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117553_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116324","volume":"248","author":"Samara","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117553_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.116994","article-title":"Analytical quality by design and measurement uncertainty in the development of discriminative dissolution method for pediatric fixed-dose combination dispersible tablets of isoniazid and rifampicin","volume":"265","author":"dos Santos","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117553_bib30","article-title":"Green analytical chemistry and quality by design: a combined approach towards simultaneous determination of Letrozole with its co-administered Zoledronic acid for cancer patients","volume":"4","author":"El-Fatah","year":"2024","journal-title":"J. Pharm. Biomed. Anal. Open"},{"key":"10.1016\/j.jpba.2026.117553_bib31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/00401706.1960.10489912","article-title":"Some new three level designs for the study of quantitative variables","volume":"2","author":"Box","year":"1960","journal-title":"Technometrics"},{"key":"10.1016\/j.jpba.2026.117553_bib32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.trac.2012.09.007","article-title":"Design spaces for analytical methods","volume":"42","author":"Rozet","year":"2013","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.jpba.2026.117553_bib33","series-title":"Response Surface Methodology: Process and Product Optimization Using Designed Experiments","author":"Myers","year":"2016"},{"key":"10.1016\/j.jpba.2026.117553_bib34","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/00224065.1980.11980968","article-title":"Simultaneous optimization of several response variables","volume":"12","author":"Derringer","year":"1980","journal-title":"J. Qual. Technol."},{"key":"10.1016\/j.jpba.2026.117553_bib35","series-title":"Validation of Analytical Procedures: Text and Methodology","author":"International Council for Harmonisation, ICH Q2 (R1)","year":"2005"},{"key":"10.1016\/j.jpba.2026.117553_bib36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2008.05.010","article-title":"Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles","volume":"132","author":"Kratz","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpba.2026.117553_bib37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jconrel.2011.09.069","article-title":"Impact of albumin on drug delivery-new applications on the horizon","volume":"157","author":"Elsadek","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpba.2026.117553_bib38","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1021\/acs.oprd.9b00238","article-title":"Development and optimization of liquid chromatography analytical methods by using AQbD principles: overview and recent advances","volume":"23","author":"Tome","year":"2019","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.jpba.2026.117553_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/435129","article-title":"Analytical quality by design approach to test method development and validation in drug substance manufacturing","volume":"2015","author":"Raman","year":"2015","journal-title":"J. Chem."},{"key":"10.1016\/j.jpba.2026.117553_bib40","first-page":"39","article-title":"Quality by design in stability testing of pharmaceuticals","volume":"17","author":"Terzic","year":"2012","journal-title":"Accred. Qual. Assur"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526002219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526002219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:21:01Z","timestamp":1780528861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708526002219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":40,"alternative-id":["S0731708526002219"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117553","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analytical quality by design-based development and validation of a robust impurity analysis method for albumin-bound paclitaxel nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117553","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117553"}}